Cochleate formulations of Amphotericin b designed for oral administration using a naturally occurring phospholipid

The purpose of this work was to formulate the poor soluble antifungal and antiparasitic agent Amphotericin B (AmB) in cost-effective lipid-based formulations suitable for oral use in developing countries, overcoming the limitations of poor water solubility, nephrotoxicity and low oral bioavailabilit...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of pharmaceutics Vol. 603
Main Authors Lipa-Castro, Antonio, Nicolas, Valérie, Angelova, Angelina, Mekhloufi, Ghozlene, Prost, Bastien, Chéron, Monique, Faivre, Vincent, Barratt, Gillian
Format Journal Article
LanguageEnglish
Published Elsevier 2021
Subjects
Galenic pharmacology
Life Sciences
Pharmaceutical sciences
phosphatidylserine
Cochleates
Caco2 cells
Amphotericin B
circular dichroism
synchrotron SAXS
oral bioavailability
Online AccessGet full text

Cover

More Information
Summary:The purpose of this work was to formulate the poor soluble antifungal and antiparasitic agent Amphotericin B (AmB) in cost-effective lipid-based formulations suitable for oral use in developing countries, overcoming the limitations of poor water solubility, nephrotoxicity and low oral bioavailability. The antifungal agent was formulated, at different molar proportions, in cochleate nanocarriers prepared using an accessible naturally occurring phospholipid rich in phosphatidylserine (Lipoid PSP70). These nanoassemblies were prepared by condensation of negatively charged phospholipid membrane vesicles with divalent cations (Ca2+). Small-angle X-ray scattering studies revealed the Ca2+-triggered condensation of loosely packed multilamellar vesicles into tightly packed bilayers of strongly dehydrated multilamellar organization characterized by narrow Bragg peaks. Transmission electron microscopy and quasi-elastic light scattering studies demonstrated the formation of nanosized particles. AmB drug loading was above 55% in all formulations. Circular dichroism demonstrated the prevalence of monomeric and complexed forms of AmB over toxic aggregates. The stability of AmB in gastric medium was improved by loading in cochleates and its release in gastrointestinal media was retarded. Confocal microscopy studies revealed the in-vitro interactions of Lipoid PSP70-based cochleates with Caco2 intestinal cell monolayers. The results suggest that the low-cost AmB-loaded cochleates may increase the therapeutic range of this drug.
ISSN:0378-5173
DOI:10.1016/j.ijpharm.2021.120688